Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://chiaraugtt305448.getblogs.net/71421157/trelaglutide-exploring-a-new-therapy-for-chronic-diseases